- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The sale of Piramal Pharma's decommissioned unit located in Thane has faced delays, as certain conditions in the previously signed MOU with Sankalpan Architects Private Limited remain unmet. As a result, the timeline for the completion of this sale has been extended indefinitely. The company will also consider other alternatives regarding this unit. Importantly, the decommissioning of the unit does not affect the company's ongoing operations, indicating stability in its current business activities. Investors should maintain a watchful eye on any further developments surrounding this asset, as it could signal strategic shifts or opportunities for the company moving forward.